Bausch Health Companies Inc. buy Vassago1
Start price
08.11.16
/
50%
€14.01
Target price
08.05.17
€15.33
Performance (%)
-37.00%
End price
08.05.17
€8.83
Summary
This prediction ended on 08.05.17 with a price of €8.83. Massive losses of -37.00% were the result for the BUY prediction by Vassago1. Vassago1 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bausch Health Companies Inc. | -3.850% | -3.850% | -31.600% | -53.740% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by Vassago1 for this prediction
In the thread Bausch Health Companies Inc. diskutieren
VRX
The Canadian firm now expects adjusted earnings of $5.30 to $5.50 a share on $9.55 billion to $9.65 billion in sales for the year. That is down sharply from its previous guidance for earnings of $6.60 to $7 a share and revenue between $9.9 billion and $10.1 billion.
(Laufzeit überschritten)